Thursday, October 29, 2009

Interview with Philip Low About Roche and NeuroVigil Partnership

Filed under: Medgadget Exclusive , Neurology

Yesterday Philip Low of NeuroVigil spoke at TEDMED and demonstrated the amazing iBrain technology his firm developed to monitor and interpret EEG signals. Today NeuroVigil announced a partnership with Roche that would provide the iBrain for use in outpatient clinical trials. We were lucky to be able to grab a few minutes of Philip's time immediately after the announcement to explain what this news means to our audience:

Press release: NeuroVigil and Roche Launch Personalized Neurodiagnostics Initiative for Enabling Preventive Treatment of CNS Disorders ...

email this article to a friend      print this!           comments and peer reviews (0)






replies: 0 comments
Open comments are not moderated, although abusive and vulgar remarks may be deleted. Opinions expressed do not necessarily reflect the views of Medgadget.com. Please consult our disclaimer.

add a comment
html tags: <b>, <i>, and <a>
examples: <b>Bold</b> <i>Italic</i>









Remember personal info?
(anonymous comments allowed)



click to make your selection boldclick to make your selection italicclick to add a link


Verification (needed to reduce spam):




Click the "Post" button only once!